NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MUCINEX D is an oral extended-release combination tablet containing guaifenesin (expectorant) and pseudoephedrine HCl (decongestant) approved in 2004. It is indicated for temporary relief of nasal congestion and productive cough associated with common cold, bronchitis, and flu. The guaifenesin component helps thin mucus to make coughs more productive, while pseudoephedrine reduces nasal swelling.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), signaling potential team consolidation or transition planning rather than expansion.
Mechanism of Action
Pharmacologic Class:
Expectorant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions
Started Dec 2014
80 enrolled
Healthy
Career Relevance
Working on MUCINEX D offers limited growth trajectory given its LOE-approaching status and zero linked job openings, making it primarily a consolidation and efficiency-focused role. This product is better suited for professionals seeking stable, execution-focused positions rather than career advancement opportunities.
Brand Manager
Worked on MUCINEX D at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.